DIA/FDA Oligonucleotide-Based Therapeutics Conference

会议日程

Click printable agenda to view full session times, locations, and speakers. Ideal for offline use or sharing!

天 1 2024 年 10 月 28 日

11:00 AM — 12:30 PM

Session 2 Track 3: Regulatory Experiences with Clinical/ Commercial Oligonucleotides

1:30 PM — 3:00 PM

Session 3 Track 3: Emerging Oligonucleotide CMC Guidance

3:30 PM — 4:45 PM

Session 4 Track 3: Demonstrating Comparability for Oligonucleotides Therapeutics

天 2 2024 年 10 月 29 日

10:00 AM — 11:30 AM

Session 6 Track 3: CMC Considerations in Development of mRNA-based Therapeutics

12:45 PM — 2:15 PM

Session 7 Track 3: Challenges Around Oligonucleotides Control Strategies

天 3 2024 年 10 月 30 日

8:00 AM — 9:15 AM

Session 9 Track 3: Innovative Manufacturing Approaches and Regulatory Implications

9:25 AM — 10:40 AM

Session 10 Track 3: Streamlining Oligonucleotide Development with Platform Approaches Roundtable